검색
검색 팝업 닫기

Advanced search

Article

Split Viewer

Online first

J Chest Surg

Published online February 20, 2025 https://doi.org/10.5090/jcs.24.073

Copyright © Journal of Chest Surgery.

Prognostic Value of Cardiac Biomarkers in Patients Undergoing On-Pump Coronary Artery Bypass Grafting: A Cohort Study in An Iranian Population

Reza Ebadi , M.D.1, Younes Nozari , M.D.2, Mina Pashang , M.Sc.2, Vanoushe Azimi Pirsaraei , M.D.3, Hamid Khederlou , M.D.4

1Department of Cardiology, Ardabil University of Medical Sciences, Ardabil; 2Tehran Heart Center, Tehran University of Medical Sciences, Tehran; 3Student Research Committee, School of Medicine, Zanjan University of Medical Sciences; 4Department of Cardiology, Zanjan University of Medical Sciences, Zanjan, Iran

Correspondence to:Hamid Khederlou
Tel 98-9125426158
Fax 98-24 334019
E-mail dr.khederlou@zums.ac.ir
ORCID https://orcid.org/0000-0001-8606-2381

Received: July 15, 2024; Revised: December 20, 2024; Accepted: December 22, 2024

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background: The predictive value of creatine kinase-myocardial band (CK-MB) and highsensitivity troponin T (hs-TnT) for adverse outcomes in coronary artery bypass grafting (CABG) has been well established in previous studies. However, most of these investigations have focused on perioperative complications. The present study assessed the preoperative and postoperative prognostic value of hs-TnT and CK-MB in individuals undergoing on-pump CABG.
Methods: This cohort study included patients who underwent isolated on-pump CABG at a tertiary hospital, Tehran Heart Center, between November 2018 and March 2021. We evaluated the associations of preoperative and postoperative hs-TnT and CK-MB levels with the incidence of major adverse cardiovascular events (MACE) within 1 year after surgery.
Results: Of the 3,188 participants, 231 (7.2%) experienced MACE. Factors associated with a higher incidence of MACE included older age, diabetes mellitus, history of peripheral vascular disease, lower left ventricular ejection fraction, and the occurrence of acute kidney injury after surgery. The adjusted hazard ratios (HRs) for the association between hs-TnT levels and 1-year MACE were 1.17 (95% confidence interval [CI], 1.07–1.29; p<0.001) for preoperative levels, 1.22 (95% CI, 1.02–1.47; p=0.044) at 8 hours post-surgery, and 1.38 (95% CI, 1.17–1.62; p<0.001) at 24 hours post-surgery. CK-MB levels at 8 hours (HR, 1.05; 95% CI, 1.01–1.10; p=0.023) and 24 hours (HR, 1.07; 95% CI, 1.04–1.10; p<0.001) after surgery were also associated with adverse events.
Conclusion: Preoperative and postoperative serum levels of hs-TnT and CK-MB may be considered significant predictors of MACE within 1 year after on-pump CABG.

Keywords: Troponin, Myocardial creatine kinase, Coronary artery bypass surgery, Major adverse cardiac event

Article

ahead

J Chest Surg

Published online February 20, 2025 https://doi.org/10.5090/jcs.24.073

Copyright © Journal of Chest Surgery.

Prognostic Value of Cardiac Biomarkers in Patients Undergoing On-Pump Coronary Artery Bypass Grafting: A Cohort Study in An Iranian Population

Reza Ebadi , M.D.1, Younes Nozari , M.D.2, Mina Pashang , M.Sc.2, Vanoushe Azimi Pirsaraei , M.D.3, Hamid Khederlou , M.D.4

1Department of Cardiology, Ardabil University of Medical Sciences, Ardabil; 2Tehran Heart Center, Tehran University of Medical Sciences, Tehran; 3Student Research Committee, School of Medicine, Zanjan University of Medical Sciences; 4Department of Cardiology, Zanjan University of Medical Sciences, Zanjan, Iran

Correspondence to:Hamid Khederlou
Tel 98-9125426158
Fax 98-24 334019
E-mail dr.khederlou@zums.ac.ir
ORCID https://orcid.org/0000-0001-8606-2381

Received: July 15, 2024; Revised: December 20, 2024; Accepted: December 22, 2024

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background: The predictive value of creatine kinase-myocardial band (CK-MB) and highsensitivity troponin T (hs-TnT) for adverse outcomes in coronary artery bypass grafting (CABG) has been well established in previous studies. However, most of these investigations have focused on perioperative complications. The present study assessed the preoperative and postoperative prognostic value of hs-TnT and CK-MB in individuals undergoing on-pump CABG.
Methods: This cohort study included patients who underwent isolated on-pump CABG at a tertiary hospital, Tehran Heart Center, between November 2018 and March 2021. We evaluated the associations of preoperative and postoperative hs-TnT and CK-MB levels with the incidence of major adverse cardiovascular events (MACE) within 1 year after surgery.
Results: Of the 3,188 participants, 231 (7.2%) experienced MACE. Factors associated with a higher incidence of MACE included older age, diabetes mellitus, history of peripheral vascular disease, lower left ventricular ejection fraction, and the occurrence of acute kidney injury after surgery. The adjusted hazard ratios (HRs) for the association between hs-TnT levels and 1-year MACE were 1.17 (95% confidence interval [CI], 1.07–1.29; p<0.001) for preoperative levels, 1.22 (95% CI, 1.02–1.47; p=0.044) at 8 hours post-surgery, and 1.38 (95% CI, 1.17–1.62; p<0.001) at 24 hours post-surgery. CK-MB levels at 8 hours (HR, 1.05; 95% CI, 1.01–1.10; p=0.023) and 24 hours (HR, 1.07; 95% CI, 1.04–1.10; p<0.001) after surgery were also associated with adverse events.
Conclusion: Preoperative and postoperative serum levels of hs-TnT and CK-MB may be considered significant predictors of MACE within 1 year after on-pump CABG.

Keywords: Troponin, Myocardial creatine kinase, Coronary artery bypass surgery, Major adverse cardiac event

There is no Figure.

There is no Table.

There is no Reference.

Share this article on :

  • line